Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Molecular Laboratory Diagnostic Kits Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Molecular Laboratory Diagnostic Kits Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-08-05
Pages: 199 Pages
Report ld: 4891978
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Molecular Laboratory Diagnostic Kits market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Rapid extraction of viral DNA or RNA from plasma, serum, urine, ascites, cell culture fluid, supernatant, cell-free body fluid, can be used in various common downstream experiments, such as restriction digestion, reverse transcription, etc.
The global medical device market is estimated to be US$603.3 billion in 2023, with a compound annual growth rate of 5% expected in the next six years. Global health care expenditure currently accounts for approximately 10% of global GDP, and the proportion will continue to increase in the next few years. This is primarily due to the increasing demand for healthcare from an aging population, the rising prevalence of chronic and infectious diseases, and the expansion of emerging markets. The medical device market plays an important role in the healthcare spending industry. The medical device market is driven by a variety of factors, including increasing global demand for advanced medical services, advancements in medical technology, growing geriatric population, increasing medical expenditures, and increasing awareness of early stage disease diagnosis and treatment.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Molecular Laboratory Diagnostic Kits market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Seegene
- SPACEGEN
- VITASSAY HEALTHCARE S.L.
- Yaneng Bioscience (Shenzhen) Co., Ltd.
- Zhejiang Orient Gene
- ELITech Group
- Fujirebio
- Jiangsu Bioperfectus Technologies Co., Ltd.
- Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
- Altona Diagnostics GmbH
- NZYTech
- ATTOPLEX
- OSANG Healthcare
- Panagene Inc.
- PCRmax
- R-Biopharm AG
- AB Analitica
- Celnovte Biotechnology Co., Ltd.
- Elisabeth Pharmacon Spol
- Jiangsu Mole Bioscience CO., LTD.
- Medical Innovation Ventures
- Randox Laboratories
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Infectious Disease
- Respiratory Disease
- Gastrointestinal Disease
- Others
Segment by Application
- Hospital
- Clinic
- Research Center
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Molecular Laboratory Diagnostic Kits study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Molecular Laboratory Diagnostic Kits: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Molecular Laboratory Diagnostic Kits Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Infectious Disease
1.2.3 Respiratory Disease
1.2.4 Gastrointestinal Disease
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Molecular Laboratory Diagnostic Kits Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Center
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Molecular Laboratory Diagnostic Kits Revenue Estimates and Forecasts 2020-2031
2.2 Global Molecular Laboratory Diagnostic Kits Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Molecular Laboratory Diagnostic Kits Sales Estimates and Forecasts 2020-2031
2.4 Global Molecular Laboratory Diagnostic Kits Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Molecular Laboratory Diagnostic Kits Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Molecular Laboratory Diagnostic Kits Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Infectious Disease Market Size by Manufacturers
3.5.2 Respiratory Disease Market Size by Manufacturers
3.5.3 Gastrointestinal Disease Market Size by Manufacturers
3.5.4 Others Market Size by Manufacturers
3.6 Global Molecular Laboratory Diagnostic Kits Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Molecular Laboratory Diagnostic Kits Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Molecular Laboratory Diagnostic Kits Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Molecular Laboratory Diagnostic Kits Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Molecular Laboratory Diagnostic Kits Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Molecular Laboratory Diagnostic Kits Sales and Revenue by Type (2020-2031)
6.4 North America Molecular Laboratory Diagnostic Kits Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Molecular Laboratory Diagnostic Kits Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Molecular Laboratory Diagnostic Kits Sales and Revenue by Type (2020-2031)
7.4 Europe Molecular Laboratory Diagnostic Kits Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Molecular Laboratory Diagnostic Kits Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Molecular Laboratory Diagnostic Kits Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Molecular Laboratory Diagnostic Kits Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Molecular Laboratory Diagnostic Kits Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Molecular Laboratory Diagnostic Kits Sales and Revenue by Type (2020-2031)
9.4 Central and South America Molecular Laboratory Diagnostic Kits Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Molecular Laboratory Diagnostic Kits Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Molecular Laboratory Diagnostic Kits Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Molecular Laboratory Diagnostic Kits Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Molecular Laboratory Diagnostic Kits Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Seegene
11.1.1 Seegene Corporation Information
11.1.2 Seegene Business Overview
11.1.3 Seegene Molecular Laboratory Diagnostic Kits Product Models, Descriptions and Specifications
11.1.4 Seegene Molecular Laboratory Diagnostic Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Seegene Molecular Laboratory Diagnostic Kits Sales by Product in 2024
11.1.6 Seegene Molecular Laboratory Diagnostic Kits Sales by Application in 2024
11.1.7 Seegene Molecular Laboratory Diagnostic Kits Sales by Geographic Area in 2024
11.1.8 Seegene Molecular Laboratory Diagnostic Kits SWOT Analysis
11.1.9 Seegene Recent Developments
11.2 SPACEGEN
11.2.1 SPACEGEN Corporation Information
11.2.2 SPACEGEN Business Overview
11.2.3 SPACEGEN Molecular Laboratory Diagnostic Kits Product Models, Descriptions and Specifications
11.2.4 SPACEGEN Molecular Laboratory Diagnostic Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 SPACEGEN Molecular Laboratory Diagnostic Kits Sales by Product in 2024
11.2.6 SPACEGEN Molecular Laboratory Diagnostic Kits Sales by Application in 2024
11.2.7 SPACEGEN Molecular Laboratory Diagnostic Kits Sales by Geographic Area in 2024
11.2.8 SPACEGEN Molecular Laboratory Diagnostic Kits SWOT Analysis
11.2.9 SPACEGEN Recent Developments
11.3 VITASSAY HEALTHCARE S.L.
11.3.1 VITASSAY HEALTHCARE S.L. Corporation Information
11.3.2 VITASSAY HEALTHCARE S.L. Business Overview
11.3.3 VITASSAY HEALTHCARE S.L. Molecular Laboratory Diagnostic Kits Product Models, Descriptions and Specifications
11.3.4 VITASSAY HEALTHCARE S.L. Molecular Laboratory Diagnostic Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 VITASSAY HEALTHCARE S.L. Molecular Laboratory Diagnostic Kits Sales by Product in 2024
11.3.6 VITASSAY HEALTHCARE S.L. Molecular Laboratory Diagnostic Kits Sales by Application in 2024
11.3.7 VITASSAY HEALTHCARE S.L. Molecular Laboratory Diagnostic Kits Sales by Geographic Area in 2024
11.3.8 VITASSAY HEALTHCARE S.L. Molecular Laboratory Diagnostic Kits SWOT Analysis
11.3.9 VITASSAY HEALTHCARE S.L. Recent Developments
11.4 Yaneng Bioscience (Shenzhen) Co., Ltd.
11.4.1 Yaneng Bioscience (Shenzhen) Co., Ltd. Corporation Information
11.4.2 Yaneng Bioscience (Shenzhen) Co., Ltd. Business Overview
11.4.3 Yaneng Bioscience (Shenzhen) Co., Ltd. Molecular Laboratory Diagnostic Kits Product Models, Descriptions and Specifications
11.4.4 Yaneng Bioscience (Shenzhen) Co., Ltd. Molecular Laboratory Diagnostic Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Yaneng Bioscience (Shenzhen) Co., Ltd. Molecular Laboratory Diagnostic Kits Sales by Product in 2024
11.4.6 Yaneng Bioscience (Shenzhen) Co., Ltd. Molecular Laboratory Diagnostic Kits Sales by Application in 2024
11.4.7 Yaneng Bioscience (Shenzhen) Co., Ltd. Molecular Laboratory Diagnostic Kits Sales by Geographic Area in 2024
11.4.8 Yaneng Bioscience (Shenzhen) Co., Ltd. Molecular Laboratory Diagnostic Kits SWOT Analysis
11.4.9 Yaneng Bioscience (Shenzhen) Co., Ltd. Recent Developments
11.5 Zhejiang Orient Gene
11.5.1 Zhejiang Orient Gene Corporation Information
11.5.2 Zhejiang Orient Gene Business Overview
11.5.3 Zhejiang Orient Gene Molecular Laboratory Diagnostic Kits Product Models, Descriptions and Specifications
11.5.4 Zhejiang Orient Gene Molecular Laboratory Diagnostic Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Zhejiang Orient Gene Molecular Laboratory Diagnostic Kits Sales by Product in 2024
11.5.6 Zhejiang Orient Gene Molecular Laboratory Diagnostic Kits Sales by Application in 2024
11.5.7 Zhejiang Orient Gene Molecular Laboratory Diagnostic Kits Sales by Geographic Area in 2024
11.5.8 Zhejiang Orient Gene Molecular Laboratory Diagnostic Kits SWOT Analysis
11.5.9 Zhejiang Orient Gene Recent Developments
11.6 ELITech Group
11.6.1 ELITech Group Corporation Information
11.6.2 ELITech Group Business Overview
11.6.3 ELITech Group Molecular Laboratory Diagnostic Kits Product Models, Descriptions and Specifications
11.6.4 ELITech Group Molecular Laboratory Diagnostic Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 ELITech Group Recent Developments
11.7 Fujirebio
11.7.1 Fujirebio Corporation Information
11.7.2 Fujirebio Business Overview
11.7.3 Fujirebio Molecular Laboratory Diagnostic Kits Product Models, Descriptions and Specifications
11.7.4 Fujirebio Molecular Laboratory Diagnostic Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Fujirebio Recent Developments
11.8 Jiangsu Bioperfectus Technologies Co., Ltd.
11.8.1 Jiangsu Bioperfectus Technologies Co., Ltd. Corporation Information
11.8.2 Jiangsu Bioperfectus Technologies Co., Ltd. Business Overview
11.8.3 Jiangsu Bioperfectus Technologies Co., Ltd. Molecular Laboratory Diagnostic Kits Product Models, Descriptions and Specifications
11.8.4 Jiangsu Bioperfectus Technologies Co., Ltd. Molecular Laboratory Diagnostic Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Jiangsu Bioperfectus Technologies Co., Ltd. Recent Developments
11.9 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
11.9.1 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Corporation Information
11.9.2 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Business Overview
11.9.3 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Molecular Laboratory Diagnostic Kits Product Models, Descriptions and Specifications
11.9.4 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Molecular Laboratory Diagnostic Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Recent Developments
11.10 Altona Diagnostics GmbH
11.10.1 Altona Diagnostics GmbH Corporation Information
11.10.2 Altona Diagnostics GmbH Business Overview
11.10.3 Altona Diagnostics GmbH Molecular Laboratory Diagnostic Kits Product Models, Descriptions and Specifications
11.10.4 Altona Diagnostics GmbH Molecular Laboratory Diagnostic Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Altona Diagnostics GmbH Recent Developments
11.11 NZYTech
11.11.1 NZYTech Corporation Information
11.11.2 NZYTech Business Overview
11.11.3 NZYTech Molecular Laboratory Diagnostic Kits Product Models, Descriptions and Specifications
11.11.4 NZYTech Molecular Laboratory Diagnostic Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 NZYTech Recent Developments
11.12 ATTOPLEX
11.12.1 ATTOPLEX Corporation Information
11.12.2 ATTOPLEX Business Overview
11.12.3 ATTOPLEX Molecular Laboratory Diagnostic Kits Product Models, Descriptions and Specifications
11.12.4 ATTOPLEX Molecular Laboratory Diagnostic Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 ATTOPLEX Recent Developments
11.13 OSANG Healthcare
11.13.1 OSANG Healthcare Corporation Information
11.13.2 OSANG Healthcare Business Overview
11.13.3 OSANG Healthcare Molecular Laboratory Diagnostic Kits Product Models, Descriptions and Specifications
11.13.4 OSANG Healthcare Molecular Laboratory Diagnostic Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 OSANG Healthcare Recent Developments
11.14 Panagene Inc.
11.14.1 Panagene Inc. Corporation Information
11.14.2 Panagene Inc. Business Overview
11.14.3 Panagene Inc. Molecular Laboratory Diagnostic Kits Product Models, Descriptions and Specifications
11.14.4 Panagene Inc. Molecular Laboratory Diagnostic Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Panagene Inc. Recent Developments
11.15 PCRmax
11.15.1 PCRmax Corporation Information
11.15.2 PCRmax Business Overview
11.15.3 PCRmax Molecular Laboratory Diagnostic Kits Product Models, Descriptions and Specifications
11.15.4 PCRmax Molecular Laboratory Diagnostic Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 PCRmax Recent Developments
11.16 R-Biopharm AG
11.16.1 R-Biopharm AG Corporation Information
11.16.2 R-Biopharm AG Business Overview
11.16.3 R-Biopharm AG Molecular Laboratory Diagnostic Kits Product Models, Descriptions and Specifications
11.16.4 R-Biopharm AG Molecular Laboratory Diagnostic Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 R-Biopharm AG Recent Developments
11.17 AB Analitica
11.17.1 AB Analitica Corporation Information
11.17.2 AB Analitica Business Overview
11.17.3 AB Analitica Molecular Laboratory Diagnostic Kits Product Models, Descriptions and Specifications
11.17.4 AB Analitica Molecular Laboratory Diagnostic Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 AB Analitica Recent Developments
11.18 Celnovte Biotechnology Co., Ltd.
11.18.1 Celnovte Biotechnology Co., Ltd. Corporation Information
11.18.2 Celnovte Biotechnology Co., Ltd. Business Overview
11.18.3 Celnovte Biotechnology Co., Ltd. Molecular Laboratory Diagnostic Kits Product Models, Descriptions and Specifications
11.18.4 Celnovte Biotechnology Co., Ltd. Molecular Laboratory Diagnostic Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 Celnovte Biotechnology Co., Ltd. Recent Developments
11.19 Elisabeth Pharmacon Spol
11.19.1 Elisabeth Pharmacon Spol Corporation Information
11.19.2 Elisabeth Pharmacon Spol Business Overview
11.19.3 Elisabeth Pharmacon Spol Molecular Laboratory Diagnostic Kits Product Models, Descriptions and Specifications
11.19.4 Elisabeth Pharmacon Spol Molecular Laboratory Diagnostic Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 Elisabeth Pharmacon Spol Recent Developments
11.20 Jiangsu Mole Bioscience CO., LTD.
11.20.1 Jiangsu Mole Bioscience CO., LTD. Corporation Information
11.20.2 Jiangsu Mole Bioscience CO., LTD. Business Overview
11.20.3 Jiangsu Mole Bioscience CO., LTD. Molecular Laboratory Diagnostic Kits Product Models, Descriptions and Specifications
11.20.4 Jiangsu Mole Bioscience CO., LTD. Molecular Laboratory Diagnostic Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.20.5 Jiangsu Mole Bioscience CO., LTD. Recent Developments
11.21 Medical Innovation Ventures
11.21.1 Medical Innovation Ventures Corporation Information
11.21.2 Medical Innovation Ventures Business Overview
11.21.3 Medical Innovation Ventures Molecular Laboratory Diagnostic Kits Product Models, Descriptions and Specifications
11.21.4 Medical Innovation Ventures Molecular Laboratory Diagnostic Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.21.5 Medical Innovation Ventures Recent Developments
11.22 Randox Laboratories
11.22.1 Randox Laboratories Corporation Information
11.22.2 Randox Laboratories Business Overview
11.22.3 Randox Laboratories Molecular Laboratory Diagnostic Kits Product Models, Descriptions and Specifications
11.22.4 Randox Laboratories Molecular Laboratory Diagnostic Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.22.5 Randox Laboratories Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Molecular Laboratory Diagnostic Kits Industry Chain
12.2 Molecular Laboratory Diagnostic Kits Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Molecular Laboratory Diagnostic Kits Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Molecular Laboratory Diagnostic Kits Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Molecular Laboratory Diagnostic Kits Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Molecular Laboratory Diagnostic Kits Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Molecular Laboratory Diagnostic Kits Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Molecular Laboratory Diagnostic Kits Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Molecular Laboratory Diagnostic Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Molecular Laboratory Diagnostic Kits Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Molecular Laboratory Diagnostic Kits Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Molecular Laboratory Diagnostic Kits Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Molecular Laboratory Diagnostic Kits Sales by Region (2020-2025) & (K Units)
Table 8. Global Molecular Laboratory Diagnostic Kits Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Molecular Laboratory Diagnostic Kits Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Molecular Laboratory Diagnostic Kits Sales Share by Manufacturers (2020-2025)
Table 12. Global Molecular Laboratory Diagnostic Kits Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Molecular Laboratory Diagnostic Kits Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Molecular Laboratory Diagnostic Kits by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Laboratory Diagnostic Kits as of 2024)
Table 16. Global Molecular Laboratory Diagnostic Kits Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Molecular Laboratory Diagnostic Kits Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Molecular Laboratory Diagnostic Kits Manufacturing Base and Headquarters
Table 19. Global Molecular Laboratory Diagnostic Kits Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Molecular Laboratory Diagnostic Kits Sales by Type (2020-2025) & (K Units)
Table 23. Global Molecular Laboratory Diagnostic Kits Sales by Type (2026-2031) & (K Units)
Table 24. Global Molecular Laboratory Diagnostic Kits Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Molecular Laboratory Diagnostic Kits Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Molecular Laboratory Diagnostic Kits ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Molecular Laboratory Diagnostic Kits Sales by Application (2020-2025) & (K Units)
Table 29. Global Molecular Laboratory Diagnostic Kits Sales by Application (2026-2031) & (K Units)
Table 30. Molecular Laboratory Diagnostic Kits High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Molecular Laboratory Diagnostic Kits Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Molecular Laboratory Diagnostic Kits Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Molecular Laboratory Diagnostic Kits ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Molecular Laboratory Diagnostic Kits Growth Accelerators and Market Barriers
Table 37. North America Molecular Laboratory Diagnostic Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Molecular Laboratory Diagnostic Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Molecular Laboratory Diagnostic Kits Growth Accelerators and Market Barriers
Table 40. Europe Molecular Laboratory Diagnostic Kits Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Molecular Laboratory Diagnostic Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Molecular Laboratory Diagnostic Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Molecular Laboratory Diagnostic Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Molecular Laboratory Diagnostic Kits Growth Accelerators and Market Barriers
Table 45. Southeast Asia Molecular Laboratory Diagnostic Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Molecular Laboratory Diagnostic Kits Investment Opportunities and Key Challenges
Table 47. Central and South America Molecular Laboratory Diagnostic Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Molecular Laboratory Diagnostic Kits Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Molecular Laboratory Diagnostic Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Seegene Corporation Information
Table 51. Seegene Description and Major Businesses
Table 52. Seegene Product Models, Descriptions and Specifications
Table 53. Seegene Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Seegene Sales Value Proportion by Product in 2024
Table 55. Seegene Sales Value Proportion by Application in 2024
Table 56. Seegene Sales Value Proportion by Geographic Area in 2024
Table 57. Seegene Molecular Laboratory Diagnostic Kits SWOT Analysis
Table 58. Seegene Recent Developments
Table 59. SPACEGEN Corporation Information
Table 60. SPACEGEN Description and Major Businesses
Table 61. SPACEGEN Product Models, Descriptions and Specifications
Table 62. SPACEGEN Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. SPACEGEN Sales Value Proportion by Product in 2024
Table 64. SPACEGEN Sales Value Proportion by Application in 2024
Table 65. SPACEGEN Sales Value Proportion by Geographic Area in 2024
Table 66. SPACEGEN Molecular Laboratory Diagnostic Kits SWOT Analysis
Table 67. SPACEGEN Recent Developments
Table 68. VITASSAY HEALTHCARE S.L. Corporation Information
Table 69. VITASSAY HEALTHCARE S.L. Description and Major Businesses
Table 70. VITASSAY HEALTHCARE S.L. Product Models, Descriptions and Specifications
Table 71. VITASSAY HEALTHCARE S.L. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. VITASSAY HEALTHCARE S.L. Sales Value Proportion by Product in 2024
Table 73. VITASSAY HEALTHCARE S.L. Sales Value Proportion by Application in 2024
Table 74. VITASSAY HEALTHCARE S.L. Sales Value Proportion by Geographic Area in 2024
Table 75. VITASSAY HEALTHCARE S.L. Molecular Laboratory Diagnostic Kits SWOT Analysis
Table 76. VITASSAY HEALTHCARE S.L. Recent Developments
Table 77. Yaneng Bioscience (Shenzhen) Co., Ltd. Corporation Information
Table 78. Yaneng Bioscience (Shenzhen) Co., Ltd. Description and Major Businesses
Table 79. Yaneng Bioscience (Shenzhen) Co., Ltd. Product Models, Descriptions and Specifications
Table 80. Yaneng Bioscience (Shenzhen) Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Yaneng Bioscience (Shenzhen) Co., Ltd. Sales Value Proportion by Product in 2024
Table 82. Yaneng Bioscience (Shenzhen) Co., Ltd. Sales Value Proportion by Application in 2024
Table 83. Yaneng Bioscience (Shenzhen) Co., Ltd. Sales Value Proportion by Geographic Area in 2024
Table 84. Yaneng Bioscience (Shenzhen) Co., Ltd. Molecular Laboratory Diagnostic Kits SWOT Analysis
Table 85. Yaneng Bioscience (Shenzhen) Co., Ltd. Recent Developments
Table 86. Zhejiang Orient Gene Corporation Information
Table 87. Zhejiang Orient Gene Description and Major Businesses
Table 88. Zhejiang Orient Gene Product Models, Descriptions and Specifications
Table 89. Zhejiang Orient Gene Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Zhejiang Orient Gene Sales Value Proportion by Product in 2024
Table 91. Zhejiang Orient Gene Sales Value Proportion by Application in 2024
Table 92. Zhejiang Orient Gene Sales Value Proportion by Geographic Area in 2024
Table 93. Zhejiang Orient Gene Molecular Laboratory Diagnostic Kits SWOT Analysis
Table 94. Zhejiang Orient Gene Recent Developments
Table 95. ELITech Group Corporation Information
Table 96. ELITech Group Description and Major Businesses
Table 97. ELITech Group Product Models, Descriptions and Specifications
Table 98. ELITech Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. ELITech Group Recent Developments
Table 100. Fujirebio Corporation Information
Table 101. Fujirebio Description and Major Businesses
Table 102. Fujirebio Product Models, Descriptions and Specifications
Table 103. Fujirebio Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Fujirebio Recent Developments
Table 105. Jiangsu Bioperfectus Technologies Co., Ltd. Corporation Information
Table 106. Jiangsu Bioperfectus Technologies Co., Ltd. Description and Major Businesses
Table 107. Jiangsu Bioperfectus Technologies Co., Ltd. Product Models, Descriptions and Specifications
Table 108. Jiangsu Bioperfectus Technologies Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Jiangsu Bioperfectus Technologies Co., Ltd. Recent Developments
Table 110. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Corporation Information
Table 111. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Description and Major Businesses
Table 112. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Product Models, Descriptions and Specifications
Table 113. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Recent Developments
Table 115. Altona Diagnostics GmbH Corporation Information
Table 116. Altona Diagnostics GmbH Description and Major Businesses
Table 117. Altona Diagnostics GmbH Product Models, Descriptions and Specifications
Table 118. Altona Diagnostics GmbH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Altona Diagnostics GmbH Recent Developments
Table 120. NZYTech Corporation Information
Table 121. NZYTech Description and Major Businesses
Table 122. NZYTech Product Models, Descriptions and Specifications
Table 123. NZYTech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. NZYTech Recent Developments
Table 125. ATTOPLEX Corporation Information
Table 126. ATTOPLEX Description and Major Businesses
Table 127. ATTOPLEX Product Models, Descriptions and Specifications
Table 128. ATTOPLEX Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. ATTOPLEX Recent Developments
Table 130. OSANG Healthcare Corporation Information
Table 131. OSANG Healthcare Description and Major Businesses
Table 132. OSANG Healthcare Product Models, Descriptions and Specifications
Table 133. OSANG Healthcare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. OSANG Healthcare Recent Developments
Table 135. Panagene Inc. Corporation Information
Table 136. Panagene Inc. Description and Major Businesses
Table 137. Panagene Inc. Product Models, Descriptions and Specifications
Table 138. Panagene Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Panagene Inc. Recent Developments
Table 140. PCRmax Corporation Information
Table 141. PCRmax Description and Major Businesses
Table 142. PCRmax Product Models, Descriptions and Specifications
Table 143. PCRmax Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. PCRmax Recent Developments
Table 145. R-Biopharm AG Corporation Information
Table 146. R-Biopharm AG Description and Major Businesses
Table 147. R-Biopharm AG Product Models, Descriptions and Specifications
Table 148. R-Biopharm AG Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. R-Biopharm AG Recent Developments
Table 150. AB Analitica Corporation Information
Table 151. AB Analitica Description and Major Businesses
Table 152. AB Analitica Product Models, Descriptions and Specifications
Table 153. AB Analitica Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. AB Analitica Recent Developments
Table 155. Celnovte Biotechnology Co., Ltd. Corporation Information
Table 156. Celnovte Biotechnology Co., Ltd. Description and Major Businesses
Table 157. Celnovte Biotechnology Co., Ltd. Product Models, Descriptions and Specifications
Table 158. Celnovte Biotechnology Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 159. Celnovte Biotechnology Co., Ltd. Recent Developments
Table 160. Elisabeth Pharmacon Spol Corporation Information
Table 161. Elisabeth Pharmacon Spol Description and Major Businesses
Table 162. Elisabeth Pharmacon Spol Product Models, Descriptions and Specifications
Table 163. Elisabeth Pharmacon Spol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 164. Elisabeth Pharmacon Spol Recent Developments
Table 165. Jiangsu Mole Bioscience CO., LTD. Corporation Information
Table 166. Jiangsu Mole Bioscience CO., LTD. Description and Major Businesses
Table 167. Jiangsu Mole Bioscience CO., LTD. Product Models, Descriptions and Specifications
Table 168. Jiangsu Mole Bioscience CO., LTD. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 169. Jiangsu Mole Bioscience CO., LTD. Recent Developments
Table 170. Medical Innovation Ventures Corporation Information
Table 171. Medical Innovation Ventures Description and Major Businesses
Table 172. Medical Innovation Ventures Product Models, Descriptions and Specifications
Table 173. Medical Innovation Ventures Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 174. Medical Innovation Ventures Recent Developments
Table 175. Randox Laboratories Corporation Information
Table 176. Randox Laboratories Description and Major Businesses
Table 177. Randox Laboratories Product Models, Descriptions and Specifications
Table 178. Randox Laboratories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 179. Randox Laboratories Recent Developments
Table 180. Key Raw Materials Distribution
Table 181. Raw Materials Key Suppliers
Table 182. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 183. Milestones in Production Technology Evolution
Table 184. Distributors List
Table 185. Market Trends and Market Evolution
Table 186. Market Drivers and Opportunities
Table 187. Market Challenges, Risks, and Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Molecular Laboratory Diagnostic Kits Product Picture
Figure 2. Global Molecular Laboratory Diagnostic Kits Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Infectious Disease Product Picture
Figure 4. Respiratory Disease Product Picture
Figure 5. Gastrointestinal Disease Product Picture
Figure 6. Others Product Picture
Figure 7. Global Molecular Laboratory Diagnostic Kits Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Research Center
Figure 11. Others
Figure 12. Molecular Laboratory Diagnostic Kits Report Years Considered
Figure 13. Global Molecular Laboratory Diagnostic Kits Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Molecular Laboratory Diagnostic Kits Revenue (2020-2031) & (US$ Million)
Figure 15. Global Molecular Laboratory Diagnostic Kits Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global Molecular Laboratory Diagnostic Kits Revenue Market Share by Region (2020-2031)
Figure 17. Global Molecular Laboratory Diagnostic Kits Sales (2020-2031) & (K Units)
Figure 18. Global Molecular Laboratory Diagnostic Kits Sales (CAGR) by Region (2020-2031) (K Units)
Figure 19. Global Molecular Laboratory Diagnostic Kits Sales Market Share by Region (2020-2031)
Figure 20. Top 5 and Top 10 Manufacturers Molecular Laboratory Diagnostic Kits Sales Volume Market Share in 2024
Figure 21. Global Molecular Laboratory Diagnostic Kits Revenue Market Share Ranking (2024)
Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 23. Infectious Disease Revenue Market Share by Manufacturer in 2024
Figure 24. Respiratory Disease Revenue Market Share by Manufacturer in 2024
Figure 25. Gastrointestinal Disease Revenue Market Share by Manufacturer in 2024
Figure 26. Others Revenue Market Share by Manufacturer in 2024
Figure 27. Global Molecular Laboratory Diagnostic Kits Sales Market Share by Type (2020-2031)
Figure 28. Global Molecular Laboratory Diagnostic Kits Revenue Market Share by Type (2020-2031)
Figure 29. Global Molecular Laboratory Diagnostic Kits Sales Market Share by Application (2020-2031)
Figure 30. Global Molecular Laboratory Diagnostic Kits Revenue Market Share by Application (2020-2031)
Figure 31. North America Molecular Laboratory Diagnostic Kits Sales YoY (2020-2031) & (K Units)
Figure 32. North America Molecular Laboratory Diagnostic Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 33. North America Top 5 Manufacturers Molecular Laboratory Diagnostic Kits Sales Revenue (US$ Million) in 2024
Figure 34. North America Molecular Laboratory Diagnostic Kits Sales Volume (K Units) by Type (2020- 2031)
Figure 35. North America Molecular Laboratory Diagnostic Kits Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 36. North America Molecular Laboratory Diagnostic Kits Sales Volume (K Units) by Application (2020-2031)
Figure 37. North America Molecular Laboratory Diagnostic Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 38. US Molecular Laboratory Diagnostic Kits Revenue (2020-2031) & (US$ Million)
Figure 39. Canada Molecular Laboratory Diagnostic Kits Revenue (2020-2031) & (US$ Million)
Figure 40. Mexico Molecular Laboratory Diagnostic Kits Revenue (2020-2031) & (US$ Million)
Figure 41. Europe Molecular Laboratory Diagnostic Kits Sales YoY (2020-2031) & (K Units)
Figure 42. Europe Molecular Laboratory Diagnostic Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 43. Europe Top 5 Manufacturers Molecular Laboratory Diagnostic Kits Sales Revenue (US$ Million) in 2024
Figure 44. Europe Molecular Laboratory Diagnostic Kits Sales Volume (K Units) by Type (2020-2031)
Figure 45. Europe Molecular Laboratory Diagnostic Kits Sales Revenue (US$ Million) by Type (2020-2031)
Figure 46. Europe Molecular Laboratory Diagnostic Kits Sales Volume (K Units) by Application (2020-2031)
Figure 47. Europe Molecular Laboratory Diagnostic Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 48. Germany Molecular Laboratory Diagnostic Kits Revenue (2020-2031) & (US$ Million)
Figure 49. France Molecular Laboratory Diagnostic Kits Revenue (2020-2031) & (US$ Million)
Figure 50. U.K. Molecular Laboratory Diagnostic Kits Revenue (2020-2031) & (US$ Million)
Figure 51. Italy Molecular Laboratory Diagnostic Kits Revenue (2020-2031) & (US$ Million)
Figure 52. Russia Molecular Laboratory Diagnostic Kits Revenue (2020-2031) & (US$ Million)
Figure 53. Asia-Pacific Molecular Laboratory Diagnostic Kits Sales YoY (2020-2031) & (K Units)
Figure 54. Asia-Pacific Molecular Laboratory Diagnostic Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 55. Asia-Pacific Top 8 Manufacturers Molecular Laboratory Diagnostic Kits Sales Revenue (US$ Million) in 2024
Figure 56. Asia-Pacific Molecular Laboratory Diagnostic Kits Sales Volume (K Units) by Type (2020- 2031)
Figure 57. Asia-Pacific Molecular Laboratory Diagnostic Kits Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 58. Asia-Pacific Molecular Laboratory Diagnostic Kits Sales Volume (K Units) by Application (2020-2031)
Figure 59. Asia-Pacific Molecular Laboratory Diagnostic Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 60. Indonesia Molecular Laboratory Diagnostic Kits Revenue (2020-2031) & (US$ Million)
Figure 61. Japan Molecular Laboratory Diagnostic Kits Revenue (2020-2031) & (US$ Million)
Figure 62. South Korea Molecular Laboratory Diagnostic Kits Revenue (2020-2031) & (US$ Million)
Figure 63. China Taiwan Molecular Laboratory Diagnostic Kits Revenue (2020-2031) & (US$ Million)
Figure 64. India Molecular Laboratory Diagnostic Kits Revenue (2020-2031) & (US$ Million)
Figure 65. Central and South America Molecular Laboratory Diagnostic Kits Sales YoY (2020-2031) & (K Units)
Figure 66. Central and South America Molecular Laboratory Diagnostic Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 67. Central and South America Top 5 Manufacturers Molecular Laboratory Diagnostic Kits Sales Revenue (US$ Million) in 2024
Figure 68. Central and South America Molecular Laboratory Diagnostic Kits Sales Volume (K Units) by Type (2021-2031)
Figure 69. Central and South America Molecular Laboratory Diagnostic Kits Sales Revenue (US$ Million) by Type (2020-2031)
Figure 70. Central and South America Molecular Laboratory Diagnostic Kits Sales Volume (K Units) by Application (2020-2031)
Figure 71. Central and South America Molecular Laboratory Diagnostic Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 72. Brazil Molecular Laboratory Diagnostic Kits Revenue (2020-2025) & (US$ Million)
Figure 73. Argentina Molecular Laboratory Diagnostic Kits Revenue (2020-2025) & (US$ Million)
Figure 74. Middle East, and Africa Molecular Laboratory Diagnostic Kits Sales YoY (2020-2031) & (K Units)
Figure 75. Middle East and Africa Molecular Laboratory Diagnostic Kits Revenue YoY (2020-2031) & (US$ Million)
Figure 76. Middle East and Africa Top 5 Manufacturers Molecular Laboratory Diagnostic Kits Sales Revenue (US$ Million) in 2024
Figure 77. Middle East and Africa Molecular Laboratory Diagnostic Kits Sales Volume (K Units) by Type (2021-2031)
Figure 78. South America Molecular Laboratory Diagnostic Kits Sales Revenue (US$ Million) by Type (2020-2031)
Figure 79. Middle East and Africa Molecular Laboratory Diagnostic Kits Sales Volume (K Units) by Application (2020-2031)
Figure 80. Middle East and Africa Molecular Laboratory Diagnostic Kits Sales Revenue (US$ Million) by Application (2020-2031)
Figure 81. GCC Countries Molecular Laboratory Diagnostic Kits Revenue (2020-2025) & (US$ Million)
Figure 82. Turkey Molecular Laboratory Diagnostic Kits Revenue (2020-2025) & (US$ Million)
Figure 83. Egypt Molecular Laboratory Diagnostic Kits Revenue (2020-2025) & (US$ Million)
Figure 84. South Africa Molecular Laboratory Diagnostic Kits Revenue (2020-2025) & (US$ Million)
Figure 85. Molecular Laboratory Diagnostic Kits Industry Chain Mapping
Figure 86. Regional Molecular Laboratory Diagnostic Kits Manufacturing Base Distribution (%)
Figure 87. Global Molecular Laboratory Diagnostic Kits Production Market Share by Region (2020-2031)
Figure 88. Molecular Laboratory Diagnostic Kits Production Process
Figure 89. Regional Molecular Laboratory Diagnostic Kits Production Cost Structure
Figure 90. Channels of Distribution (Direct Vs Distribution)
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Molecular Laboratory Diagnostic Kits market?
The top companies in the global Molecular Laboratory Diagnostic Kits market are Seegene、SPACEGEN、VITASSAY HEALTHCARE S.L..
Related Reports
Global Molecular Laboratory Diagnostic Kits Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Molecular Laboratory Diagnostic Kits market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-27
Pages: 188
USD 4900.00
(Single User License)
Global Molecular Laboratory Diagnostic Kits Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Molecular Laboratory Diagnostic Kits market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-27
Pages: 113
USD 4250.00
(Single User License)
Molecular Laboratory Diagnostic Kits- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Molecular Laboratory Diagnostic Kits was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 151
USD 3950.00
(Single User License)
Global Molecular Laboratory Diagnostic Kits Market Research Report 2026
The global Molecular Laboratory Diagnostic Kits market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-15
Pages: 144
USD 2900.00
(Single User License)
Global Molecular Laboratory Diagnostic Kits Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Molecular Laboratory Diagnostic Kits market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 112
USD 4250.00
(Single User License)
Molecular Laboratory Diagnostic Kits - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Molecular Laboratory Diagnostic Kits was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 153
USD 3950.00
(Single User License)
Global Molecular Laboratory Diagnostic Kits Market Research Report 2025
The global market for Molecular Laboratory Diagnostic Kits was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 109
USD 2900.00
(Single User License)
Global Molecular Laboratory Diagnostic Kits Market Insights, Forecast to 2030
Rapid extraction of viral DNA or RNA from plasma, serum, urine, ascites, cell culture fluid, supernatant, cell-free body fluid, can be used in various common downstream experiments, such as restriction digestion, reverse transcription, etc.
Published Date: 2024-05-27
Pages: 190
USD 4900.00
(Single User License)
Global and Japan Molecular Laboratory Diagnostic Kits Market Report & Forecast 2024-2030
Rapid extraction of viral DNA or RNA from plasma, serum, urine, ascites, cell culture fluid, supernatant, cell-free body fluid, can be used in various common downstream experiments, such as restriction digestion, reverse transcription, etc.
Published Date: 2024-05-21
Pages: 162
USD 4350.00
(Single User License)
Molecular Laboratory Diagnostic Kits- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Rapid extraction of viral DNA or RNA from plasma, serum, urine, ascites, cell culture fluid, supernatant, cell-free body fluid, can be used in various common downstream experiments, such as restriction digestion, reverse transcription, etc.
Published Date: 2024-05-21
Pages: 152
USD 3950.00
(Single User License)
Global Molecular Laboratory Diagnostic Kits Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Molecular Laboratory Diagnostic Kits market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-27
Pages: 188
USD 4900.00 (Single User License)Global Molecular Laboratory Diagnostic Kits Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Molecular Laboratory Diagnostic Kits market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-27
Pages: 113
USD 4250.00 (Single User License)Molecular Laboratory Diagnostic Kits- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Molecular Laboratory Diagnostic Kits was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 151
USD 3950.00 (Single User License)Global Molecular Laboratory Diagnostic Kits Market Research Report 2026
The global Molecular Laboratory Diagnostic Kits market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-15
Pages: 144
USD 2900.00 (Single User License)Global Molecular Laboratory Diagnostic Kits Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Molecular Laboratory Diagnostic Kits market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 112
USD 4250.00 (Single User License)Molecular Laboratory Diagnostic Kits - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Molecular Laboratory Diagnostic Kits was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 153
USD 3950.00 (Single User License)Global Molecular Laboratory Diagnostic Kits Market Research Report 2025
The global market for Molecular Laboratory Diagnostic Kits was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 109
USD 2900.00 (Single User License)Global Molecular Laboratory Diagnostic Kits Market Insights, Forecast to 2030
Rapid extraction of viral DNA or RNA from plasma, serum, urine, ascites, cell culture fluid, supernatant, cell-free body fluid, can be used in various common downstream experiments, such as restriction digestion, reverse transcription, etc.
Published: 2024-05-27
Pages: 190
USD 4900.00 (Single User License)Global and Japan Molecular Laboratory Diagnostic Kits Market Report & Forecast 2024-2030
Rapid extraction of viral DNA or RNA from plasma, serum, urine, ascites, cell culture fluid, supernatant, cell-free body fluid, can be used in various common downstream experiments, such as restriction digestion, reverse transcription, etc.
Published: 2024-05-21
Pages: 162
USD 4350.00 (Single User License)Molecular Laboratory Diagnostic Kits- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Rapid extraction of viral DNA or RNA from plasma, serum, urine, ascites, cell culture fluid, supernatant, cell-free body fluid, can be used in various common downstream experiments, such as restriction digestion, reverse transcription, etc.
Published: 2024-05-21
Pages: 152
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now